Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Updated guidance on the management of COVID-19: from an American Thoracic Society/European Respiratory Society coordinated International Task Force (29 July 2020)
Chunxue Bai, Sanjay H. Chotirmall, Jordi Rello, et al.
European Respiratory Review (2020) Vol. 29, Iss. 157, pp. 200287-200287
Open Access | Times Cited: 120

Showing 1-25 of 120 citing articles:

Post-acute COVID-19 syndrome
Ani Nalbandian, Kartik Sehgal, Aakriti Gupta, et al.
Nature Medicine (2021) Vol. 27, Iss. 4, pp. 601-615
Open Access | Times Cited: 4248
Management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline
James D. Chalmers, Megan Crichton, Pieter Goeminne, et al.
European Respiratory Journal (2021) Vol. 57, Iss. 4, pp. 2100048-2100048
Open Access | Times Cited: 201
Deconditioning as main mechanism of impaired exercise response in COVID-19 survivors
Rocco Francesco Rinaldo, Michele Mondoni, Elena Maria Parazzini, et al.
European Respiratory Journal (2021) Vol. 58, Iss. 2, pp. 2100870-2100870
Open Access | Times Cited: 198
Impact of Corticosteroids in Coronavirus Disease 2019 Outcomes
Edison Cano Cevallos, Xavier Fonseca Fuentes, Cristina Corsini Campioli, et al.
CHEST Journal (2020) Vol. 159, Iss. 3, pp. 1019-1040
Open Access | Times Cited: 163
Therapeutics for COVID-19 and post COVID-19 complications: An update
Debdoot Basu, Vivek P. Chavda, Anita A. Mehta
Current Research in Pharmacology and Drug Discovery (2022) Vol. 3, pp. 100086-100086
Open Access | Times Cited: 68
Proteins associated with neutrophil degranulation are upregulated in nasopharyngeal swabs from SARS-CoV-2 patients
Emel Akgün, Mete Bora Tüzüner, Betül Şahin, et al.
PLoS ONE (2020) Vol. 15, Iss. 10, pp. e0240012-e0240012
Open Access | Times Cited: 103
Assessment of activities of daily living in patients post COVID-19: a systematic review
Catalina Pizarro-Pennarolli, Carlos Sánchez-Rojas, Rodrigo Torres‐Castro, et al.
PeerJ (2021) Vol. 9, pp. e11026-e11026
Open Access | Times Cited: 87
Targeting ACE2 for COVID-19 Therapy: Opportunities and Challenges
Hongpeng Jia, Enid Neptune, Honggang Cui
American Journal of Respiratory Cell and Molecular Biology (2020) Vol. 64, Iss. 4, pp. 416-425
Open Access | Times Cited: 85
Use of sit-to-stand test to assess the physical capacity and exertional desaturation in patients post COVID-19
Rodrigo Núñez‐Cortés, Gonzalo Rivera‐Lillo, Marisol Arias-Campoverde, et al.
Chronic Respiratory Disease (2021) Vol. 18
Open Access | Times Cited: 78
Flavonoids on diabetic nephropathy: advances and therapeutic opportunities
Qichao Hu, Caiyan Qu, Xiaolin Xiao, et al.
Chinese Medicine (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 74
Role of SARS-CoV-2-induced cytokine storm in multi-organ failure: Molecular pathways and potential therapeutic options
Yasaman Nazerian, Mobina Ghasemi, Younes Yassaghi, et al.
International Immunopharmacology (2022) Vol. 113, pp. 109428-109428
Open Access | Times Cited: 48
Long COVID: Complications, Underlying Mechanisms, and Treatment Strategies
Farigol Hakem Zadeh, Daniel R. Wilson, Devendra K. Agrawal
Archives of Microbiology & Immunology (2023) Vol. 07, Iss. 02
Open Access | Times Cited: 26
Reduced Diffusion Capacity in COVID-19 Survivors
Raúl Méndez, Ana Latorre, Paula González‐Jiménez, et al.
Annals of the American Thoracic Society (2021) Vol. 18, Iss. 7, pp. 1253-1255
Open Access | Times Cited: 53
Hydroxychloroquine is associated with slower viral clearance in clinical COVID-19 patients with mild to moderate disease: A retrospective study
Jihad Mallat, Fadi Hamed, Maher M. Balkis, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 51
Rapid Design and Implementation of Post-COVID-19 Clinics
Lekshmi Santhosh, Brian L. Block, Soo Yeon Kim, et al.
CHEST Journal (2021) Vol. 160, Iss. 2, pp. 671-677
Open Access | Times Cited: 46
Residual ground glass opacities three months after Covid-19 pneumonia correlate to alteration of respiratory function: The post Covid M3 study
Justine Frija‐Masson, Marie‐Pierre Debray, Samia Boussouar, et al.
Respiratory Medicine (2021) Vol. 184, pp. 106435-106435
Open Access | Times Cited: 45
The Johns Hopkins Post-Acute COVID-19 Team (PACT): A Multidisciplinary, Collaborative, Ambulatory Framework Supporting COVID-19 Survivors
Emily Brigham, Jacqueline O’Toole, Soo Yeon Kim, et al.
The American Journal of Medicine (2021) Vol. 134, Iss. 4, pp. 462-467.e1
Open Access | Times Cited: 42
Mitochondria in Focus: From Function to Therapeutic Strategies in Chronic Lung Diseases
Dayene de Assis Fernandes Caldeira, Daniel J. Weiss, Patrícia R. M. Rocco, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 42
Update June 2022: management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline
Nicolás Roche, Megan Crichton, Pieter Goeminne, et al.
European Respiratory Journal (2022) Vol. 60, Iss. 2, pp. 2200803-2200803
Open Access | Times Cited: 34
An Imaging Overview of COVID-19 ARDS in ICU Patients and Its Complications: A Pictorial Review
Nicolò Brandi, Federica Ciccarese, Maria Rita Rimondi, et al.
Diagnostics (2022) Vol. 12, Iss. 4, pp. 846-846
Open Access | Times Cited: 28
Long COVID: what is known and what gaps need to be addressed
Benjamin A. Krishna, Mark R. Wills, Nyaradzai Sithole
British Medical Bulletin (2023) Vol. 147, Iss. 1, pp. 6-19
Open Access | Times Cited: 17
The impact of COVID‐19 severity on adult survivors: Is there a relationship between vascular reactivity and cardiorespiratory fitness?
Guilherme Dionir Back, Murilo Rezende Oliveira, Guilherme Peixoto Tinoco Arêas, et al.
Physiological Reports (2025) Vol. 13, Iss. 5
Open Access
Effect of pulmonary rehabilitation for patients with long COVID-19: a systematic review and meta-analysis of randomized controlled trials
S. Li, Bing Dai, Yusheng Hou, et al.
Therapeutic Advances in Respiratory Disease (2025) Vol. 19
Open Access
Remdesivir Versus Standard-of-Care for Severe Coronavirus Disease 2019 Infection: An Analysis of 28-Day Mortality
Susan Olender, Theresa L. Walunas, Estebán Martínez, et al.
Open Forum Infectious Diseases (2021) Vol. 8, Iss. 7
Open Access | Times Cited: 35
Identification of factors impairing exercise capacity after severe COVID-19 pulmonary infection: a 3-month follow-up of prospective COVulnerability cohort
Bruno Ribeiro Baptista, Thomas d’Humières, F. Schlemmer, et al.
Respiratory Research (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 26
Page 1 - Next Page

Scroll to top